RUNX1
MOLECULAR TARGETRUNX family transcription factor 1
RUNX1 (RUNX family transcription factor 1) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting RUNX1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | molibresib | 3.81 | 44 |
| 2 | Aurintricarboxylic Acid | 1.10 | 2 |
| 3 | Dihydroxyphenylalanine | 1.10 | 2 |
| 4 | Disulfiram | 1.10 | 2 |
| 5 | Ethidium | 1.10 | 2 |
| 6 | juglone hydroxylase [Supplementary Concept] catalyzes | 1.10 | 2 |
| 7 | Daunorubicin | 0.69 | 1 |
| 8 | Fusaric Acid | 0.69 | 1 |
| 9 | Harmaline | 0.69 | 1 |
About RUNX1 as a Drug Target
RUNX1 (RUNX family transcription factor 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented RUNX1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
RUNX1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.